Treatment with Bulevirtide Improves Patient-reported Outcomes in
                    Patients with Chronic Hepatitis Delta: An Exploratory Analysis of a Phase 3
                    Trial at 48 Weeks

Buti, Marı́a; Wedemeyer, Heiner; Aleman, Soo; Chulanov, Vladimir; Morozov, Viatcheslav; Sagalova, Olga; Stepanova, Tatyana; Gish, Robert G.; Lloyd, Andrew; Kaushik, Ankita; Suri, Vithika; Manuilov, Dmitry; Osinusi, Anu; Flaherty, John F.; Lampertico, Pietro

doi:10.1055/s-0042-1760047

39. Jahrestagung Der Deutschen Arbeitsgemeinschaft Zum Studium Der Leber

2023

DOI: 10.1055/s-0042-1760047

|View full text |Cite

Treatment with Bulevirtide Improves Patient-reported Outcomes in Patients with Chronic Hepatitis Delta: An Exploratory Analysis of a Phase 3 Trial at 48 Weeks

Marı́a Buti

Heiner Wedemeyer²,

Soo Aleman

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Treatment with Bulevirtide Improves Patient-reported Outcomes in Patients with Chronic Hepatitis Delta: An Exploratory Analysis of a Phase 3 Trial at 48 Weeks

Cited by 1 publication

References 0 publications

Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022

Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022

Contact Info

Product

Resources

About